Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation

Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants

(2011) Gema Ariceta et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Complement factor I in health and disease

(2011) Sara C. Nilsson et al.   MOLECULAR IMMUNOLOGY

Eculizumab in Severe Shiga-Toxin–Associated HUS

(2011) Anne-Laure Lapeyraque et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings

(2011) Sibylle Tschumi et al.   PEDIATRIC NEPHROLOGY

Eculizumab therapy in an adult with plasma exchange-refractory atypical hemolytic uremic syndrome

(2010) Hallie C. Prescott et al.   AMERICAN JOURNAL OF HEMATOLOGY

Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome

(2010) Pilar Sánchez-Corral et al.   BRITISH JOURNAL OF HAEMATOLOGY

aHUS caused by complement dysregulation: new therapies on the horizon

(2010) Aoife M. Waters et al.   PEDIATRIC NEPHROLOGY

Hemolytic uremic syndrome due to homozygous factor H deficiency

(2009) Sidharth Kumar Sethi et al.   Clinical and Experimental Nephrology

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

(2009) C. J. Mache et al.   Clinical Journal of the American Society of Nephrology

What’s new in haemolytic uraemic syndrome?

(2008) Sally Johnson et al.   EUROPEAN JOURNAL OF PEDIATRICS

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome

(2008) Gema Ariceta et al.   PEDIATRIC NEPHROLOGY